Estimating risk of metastatic disease in T1b esophageal adenocarcinoma: incremental progress but gaps remain

Divyanshoo R Kohli¹, Prateek Sharma^{1

2}

Affiliations

¹ Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, United States.
² Gastroenterology, University of Kansas School of Medicine, Kansas City, Kansas, United States.

Editorial

Divyanshoo R Kohli et al. Endoscopy. 2022 Feb.

. 2022 Feb;54(2):118-119.

doi: 10.1055/a-1499-7516. Epub 2021 Aug 17.

Divyanshoo R Kohli¹, Prateek Sharma^{1

2}

¹ Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, United States.
² Gastroenterology, University of Kansas School of Medicine, Kansas City, Kansas, United States.

No abstract available

Conflict of interest statement

D. Kohli has received research funding from Olympus Corporation of Americas.

Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study.
Gotink AW, van de Ven SEM, Ten Kate FJC, Nieboer D, Suzuki L, Weusten BLAM, Brosens LAA, van Hillegersberg R, Alvarez Herrero L, Seldenrijk CA, Alkhalaf A, Moll FCP, Schoon EJ, van Lijnschoten I, Tang TJ, van der Valk H, Nagengast WB, Kats-Ugurlu G, Plukker JTM, Houben MHMG, van der Laan JS, Pouw RE, Bergman JJGHM, Meijer SL, van Berge Henegouwen MI, Wijnhoven BPL, de Jonge PJF, Doukas M, Bruno MJ, Biermann K, Koch AD. Gotink AW, et al. Endoscopy. 2022 Feb;54(2):109-117. doi: 10.1055/a-1399-4989. Epub 2021 May 4. Endoscopy. 2022. PMID: 33626582